Literature DB >> 29339111

Stem Cells for Urinary Incontinence: Functional Differentiation or Cytokine Effects?

Bradley C Gill1, Daniel Z Sun2, Margot S Damaser3.   

Abstract

Minimally invasive stem cell therapy for stress urinary incontinence may provide an effective nonsurgical treatment for this common condition. Clinical trials of periurethral stem cell injection have been under way, and basic science research has demonstrated the efficacy of both local and systemic stem cell therapies. Results differ as to whether stem cells have a therapeutic effect by differentiating into permanent, functional tissues or exert benefits through a transient presence and the secretion of regenerative factors. This review explores the fate of therapeutic stem cells for stress urinary incontinence and how this may relate to their mechanism of action. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29339111      PMCID: PMC6345159          DOI: 10.1016/j.urology.2018.01.002

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Assessment of the effects of autologous muscle-derived cell injections on urethral sphincter morphometry using 3D/4D ultrasound.

Authors:  Salima Ismail; Mélanie Morin; Le Mai Tu
Journal:  World J Urol       Date:  2020-01-14       Impact factor: 4.226

Review 2.  MSC-based therapy in female pelvic floor disorders.

Authors:  Yizhen Sima; Yisong Chen
Journal:  Cell Biosci       Date:  2020-09-10       Impact factor: 7.133

3.  Urethral injection of dedifferentiated fat cells ameliorates sphincter damage and voiding dysfunction in a rat model of persistence stress urinary incontinence.

Authors:  Yasutaka Murata; Daisuke Obinata; Taro Matsumoto; Yuichiro Ikado; Koichiro Kano; Noboru Fukuda; Kenya Yamaguchi; Satoru Takahashi
Journal:  Int Urol Nephrol       Date:  2022-02-17       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.